Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.54448/mdnt23S206
Submitted: 16-04-2023
Published: 16-04-2023

Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review

UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil
UNORTE - University Center of Northern São Paulo, Dentistry department, São José do Rio Preto, São Paulo, Brazil / UNIPOS - Post graduate and continuing education, Dentistry department, São José do Rio Preto, São Paulo, Brazil
Temporomandibular disorders Temporomandibular joint osteoarthritis Clinical symptoms Platelet-rich plasma

Abstract

Introduction: In the context of temporomandibular disorders (TMD), temporomandibular joint osteoarthritis (TMJOA) is a common disease in the oral and maxillofacial regions, as well as being the most severe type. The incidence of TMD is high, affecting approximately 5%-12% of the population. There is evidence for the potential superiority of intra-articular platelet-rich plasma (PRP) injections in patients with TMJOA. Objective: This study aimed to carry out a systematic review to highlight the main clinical outcomes of the minimally invasive treatment of osteoarthritis of the temporomandibular joint through the injectable use of platelet-rich plasma. Methods: The research and development of the work were carried out from December 2022 to March 2023 in the Scopus, PubMed, Science Direct, and Scielo databases, using scientific articles from 2011 to 2022, following the PRISMA rules. The quality of the studies was based on the GRADE instrument and the risk of bias by the Cochrane instrument (Funnel Plot). Results and Conclusion: It was found 134 studies that underwent eligibility analysis. The final sample had 48 eligible studies and only 25 studies were described in the systematic review. Most studies showed homogeneity in their results, with X2 =91.2% >50%, with p<0.05. The symmetrical funnel plot did not suggest a risk of bias among studies with small sample sizes. Based on the objective of the present study, important clinical outcomes of the treatment of osteoarthritis of the temporomandibular joint were evidenced through the injectable use of platelet-rich plasma, alone or in combination with other types of treatment. However, it was observed that despite the extensive literature on the use of PRP in the treatment of joint disorders, its application in TMD is still largely unexplored.

Metrics

Metrics Loading ...

References

  1. Shoukri B, Prieto JC, Ruellas A, Sugai J, StynerM. Minimally invasive approach for diagnosing TMJ osteoarthritis. J. Dent. Res. 2019, 98 (10), 1103–1111. doi:10.1177/0022034519865187.
  2. Wang XD, Zhang JN, Gan YH, Zhou YH. Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J. Dent. Res. 2015, 94 (5), 666–673. doi:10.1177/0022034515574770.
  3. Lee YH, Park HK, Nah H, Lee JS, Moon HJ, Q-Schick A. Emerging potential of exosomes in regenerative medicine for temporomandibular joint osteoarthritis. Int. J. Mol. Sci. 2020, 21 (4), 1541. doi:10.3390/ijms21041541.
  4. Figueiredo Valesan L, Da-Cas CD, Conti Réus J, Denardin ACS, Garanhani RR, Bonotto D. Prevalence of temporomandibular joint disorders: A systematic review and metaanalysis. Clin. Oral Investig. 2021, 25 (2), 441–453. doi:10.1007/s00784-020-03710-w.
  5. Al-Ani Z. Temporomandibular joint osteoarthrosis: A review of clinical aspects and management. Prim. Dent. J. 2021, 10 (1), 132–140. doi:10.1177/2050168420980977.
  6. Sha-Sha L, Li-Li X, Shuai F, Lu SJ, Jin L, Liu LK. Effect of platelet-rich plasma injection combined with individualised comprehensive physical therapy on temporomandibular joint osteoarthritis: A prospective cohort study. J. Oral Rehabil. 2022, 49 (2), 150–159. doi:10.1111/joor.13261
  7. Nitin N, Ahmed J, Sujir N, Shenoy N, Binnal A, Ongole R. Morphological assessment of TMJ spaces, mandibular condyle, and glenoid fossa using cone beam computed tomography (CBCT): a retrospective analysis. Indian J Radiol Imaging. 2021;31:78–85.
  8. List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia. 2017;37:692–704.
  9. Bitiniene D, Zamaliauskiene R, Kubilius R, Leketas M, Gailius T, Smirnovaite K. Quality of life in patients with temporomandibular disorders. A systematic review. Stomatologija. 2018;20:3–9.
  10. Kalladka M, Quek S, Heir G, Eliav E, Mupparapu M, Viswanath A. Temporomandibular joint osteoarthritis: diagnosis and long-term conservative management: a topic review. J Indian Prosthodont Soc. 2014;14:6–15.
  11. Machon V, Hirjak D, Lukas J. Therapy of the osteoarthritis of the temporomandibular joint. J Craniomaxillofac Surg. 2011;39:127–130.
  12. Wang XD, Zhang JN, Gan YH, Zhou YH. Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J Dent Res. 2015;94:666–673.
  13. de Souza RF, Lovato da Silva CH, Nasser M, Fedorowicz Z, Al-Muharraqi MA. Interventions for managing temporomandibular joint osteoarthritis. Cochrane Database Syst Rev. 2012;2012:0.
  14. Lan KW, Chen JM, Jiang LL, Feng YF, Yan Y. Treatment of condylar osteophyte in temporomandibular joint osteoarthritis with muscle balance occlusal splint and long-term follow-up: a case report. World J Clin Cases. 2022;10:4264–4272.
  15. Soni A. Arthrocentesis of temporomandibular joint- Bridging the gap between non-surgical and surgical treatment. Ann Maxillofac Surg. 2019;9:158–167.
  16. Polat ME, Yanik S. Efficiency of arthrocentesis treatment for different temporomandibular joint disorders. Int J Oral Maxillofac Surg. 2020;49:621–627.
  17. Rai D, Singh J, Somashekharappa T, Singh A. Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: one year follow up. SICOT J. 2021;7:6.
  18. Bousnaki M, Bakopoulou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac Surg. 2018;47:188–198.
  19. Lin SL, Tsai CC, Wu SL, Ko SY, Chiang WF, Yang JW. Effect of arthrocentesis plus platelet-rich plasma and platelet-rich plasma alone in the treatment of temporomandibular joint osteoarthritis: a retrospective matched cohort study (a STROBE-compliant article). Medicine (Baltimore) 2018;97:0.
  20. Abbadi W, Kara Beit Z, Al-Khanati NM. Arthrocentesis, Injectable Platelet-Rich Plasma and Combination of Both Protocols of Temporomandibular Joint Disorders Management: A Single-Blinded Randomized Clinical Trial. Cureus. 2022 Nov 11;14(11):e31396. doi: 10.7759/cureus.31396.
  21. Wu CB, Sun NN, Zhang D, Wang Q, Zhou Q. Efficacy analysis of splint combined with platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis. Front Pharmacol. 2022 Nov 14;13:996668. doi: 10.3389/fphar.2022.996668.
  22. Asadpour N, Shooshtari Z, Kazemian M, Gholami M, Vatanparast N, Samieirad S. Combined Platelet-Rich Plasma and Hyaluronic Acid can Reduce Pain in Patients Undergoing Arthrocentesis for Temporomandibular Joint Osteoarthritis. J Oral Maxillofac Surg. 2022 Sep;80(9):1474-1485. doi: 10.1016/j.joms.2022.05.002.
  23. Liu SS, Xu LL, Fan S, Lu SJ, Jin L, Liu LK, Yao Y, Cai B. Effect of platelet-rich plasma injection combined with individualised comprehensive physical therapy on temporomandibular joint osteoarthritis: A prospective cohort study. J Oral Rehabil. 2022 Feb;49(2):150-159. doi: 10.1111/joor.13261.
  24. Li FL, Wu CB, Sun HJ, Zhou Q. Comparison of Autologous Platelet-Rich Plasma and Chitosan in the Treatment of Temporomandibular Joint Osteoarthritis: A Retrospective Cohort Study. J Oral Maxillofac Surg. 2021 Feb;79(2):324-332. doi: 10.1016/j.joms.2020.09.016.
  25. Cömert Kiliç S, Güngörmüş M. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: a randomized clinical trial. Int J Oral Maxillofac Surg. 2016 Dec;45(12):1538-1544. doi: 10.1016/j.ijom.2016.06.009.

How to Cite

Manna, C. A., Costa, M., Alves Filho, C. A., & Beneti, I. M. (2023). Isolate or combined use of platelet-rich plasma in the treatment of temporomandibular joint osteoarthritis: a concise systematic review. MedNEXT Journal of Medical and Health Sciences, 4(S2). https://doi.org/10.54448/mdnt23S206